Sitagliptin BOT study

Sitagliptin BOT study - Sitagliptin B study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005499

Enrollment

Registered

2011-04-25

Start date

2010-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with type 2 diabetes

Interventions

Sitagliptin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Type 2 diabetes treated with basal-supported oral therapy 2. Patients who have a will to diet and exercise 3. Aged >or= 20 years 4. Both female and male 5. HbA1c 6.5%<or=, 10.0%> 6. No improvement in HbA1c >or= 0.5% within 3 months 7. Written informed consent by patients

Exclusion criteria

Exclusion criteria: 1. Type 1 diabetes; secondary diabetes 2. Alcoholism; severe depression or severe psychological condition 3. Malignancy 4. Patients treated without BOT therapy 5. Abnormal hemoglobinemia 6. Patients unsuitable for this study judged by physicians

Design outcomes

Primary

Measure	Time frame
Change in HbA1c	—

Countries

Japan

Contacts

Public ContactShinichi Harashima

Kyoto University Department of Diabetes and Clinical Nutrition

harasima@metab.kuhp.kyoto-u.ac.jp075-751-3560

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026